We are live on
!
Find out more
GA
Geneva Advisors Portfolio holdings
AUM
$5.81B
1-Year Est. Return
23.71%
This Fund
S&P 500
This Quarter
Est. Return
-6.12%
1 Year Est. Return
+23.71%
3 Year Est. Return
+53.12%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$4.96B
AUM Growth
-$641M
(-11%)
Cap. Flow
-$193M
Cap. Flow
% of AUM
-3.9%
Top 10 Holdings %
Top 10 Hldgs %
23.33%
Holding
765
New
46
Increased
242
Reduced
270
Closed
98
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Manhattan Associates
MANH
|
+$33.6M |
| 2 |
Amazon
AMZN
|
+$32.3M |
| 3 |
CEB
CEB Inc.
CEB
|
+$27.7M |
| 4 |
Gilead Sciences
GILD
|
+$27.3M |
| 5 |
Merck
MRK
|
+$25.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Biogen
BIIB
|
+$49.9M |
| 2 |
TWX
Time Warner Inc
TWX
|
+$30.5M |
| 3 |
SRCL
Stericycle Inc
SRCL
|
+$29.3M |
| 4 |
MIC
Macquarie Infrastructure Holdings, LLC
MIC
|
+$25M |
| 5 |
Sunoco
SUN
|
+$21.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.16% |
| 2 | Financials | 16.84% |
| 3 | Consumer Discretionary | 14.26% |
| 4 | Technology | 13.32% |
| 5 | Industrials | 10.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
Axos Financial
AX
$5.52B
| $18.1M | 0.37% |
561,852
-383,124
| -41% | -$11.4M |
|
|
KSU
77
DELISTED
Kansas City Southern
KSU
| $17.6M | 0.36% |
193,944
-30,941
| -14% | -$2.92M |
|
78
CF Industries
CF
$19B
| $16.8M | 0.34% |
373,514
-84,041
| -18% | -$4.89M |
|
79
Visa
V
$709B
| $16.5M | 0.33% |
236,182
+18,860
| +9% | +$1.35M |
|
80
Align Technology
ALGN
$11.3B
| $16.4M | 0.33% |
288,989
+22,465
| +8% | +$1.34M |
|
81
Acuity Brands
AYI
$10.2B
| $16M | 0.32% |
91,332
-42,814
| -32% | -$8.32M |
|
82
Alphabet (Google) Class A
GOOGL
$4.17T
| $15.8M | 0.32% |
+496,420
| New | +$16M |
|
|
LNKD
83
DELISTED
LinkedIn Corporation
LNKD
| $15M | 0.3% |
78,759
+3,510
| +5% | +$697K |
|
84
LyondellBasell Industries
LYB
$20.4B
| $14.7M | 0.3% |
176,913
-171,662
| -49% | -$15.3M |
|
|
SRCL
85
DELISTED
Stericycle Inc
SRCL
| $14.4M | 0.29% |
103,451
-210,174
| -67% | -$29.3M |
|
86
FTAI Aviation
FTAI
$20.5B
| $13.2M | 0.27% |
1,203,197
+1,144,647
| +1,955% | +$14.8M |
|
87
McKesson
MCK
$104B
| $13.1M | 0.26% |
70,856
+44,482
| +169% | +$9.43M |
|
88
Berkshire Hathaway Class B
BRK.B
$1.08T
| $10.3M | 0.21% |
78,747
+7,990
| +11% | +$1.09M |
|
89
Cboe Global Markets
CBOE
$32.8B
| $10.2M | 0.21% |
152,605
-25,781
| -14% | -$1.63M |
|
90
Walt Disney
DIS
$184B
| $10.2M | 0.21% |
100,146
-21,021
| -17% | -$2.29M |
|
91
Moody's
MCO
$88.2B
| $9.79M | 0.2% |
99,742
+5,245
| +6% | +$558K |
|
92
Booking.com
BKNG
$152B
| $9.53M | 0.19% |
192,600
+18,625
| +11% | +$925K |
|
93
Plains All American Pipeline
PAA
$18B
| $8.83M | 0.18% |
290,683
-38,747
| -12% | -$1.42M |
|
94
iShares Core S&P Small-Cap ETF
IJR
$111B
| $8.73M | 0.18% |
163,778
+5,270
| +3% | +$299K |
|
95
Danaher
DHR
$152B
| $8.67M | 0.17% |
151,376
+3,451
| +2% | +$204K |
|
96
Johnson & Johnson
JNJ
$640B
| $8.36M | 0.17% |
89,570
+616
| +0.7% | +$59.6K |
|
|
97
Biogen
BIIB
$32.7B
| $8.28M | 0.17% |
28,362
-150,959
| -84% | -$49.9M |
|
|
ETP
98
DELISTED
Energy Transfer Partners, L.P.
ETP
| $8.2M | 0.17% |
286,133
-533,793
| -65% | -$18.1M |
|
99
HDFC Bank
HDB
$115B
| $8.18M | 0.17% |
535,684
-169,020
| -24% | -$2.55M |
|
100
iShares Russell 2000 ETF
IWM
$81.9B
| $8.13M | 0.16% |
74,467
+6,304
| +9% | +$747K |
|
Similar funds
CAM
VKH
DL
RBC
TCM
HCM
AL
AT
Geneva Advisors's Q3 2015 Portfolio in Review
As of Q3 2015, Geneva Advisors held 765 positions worth $4.96B, down 11% from $5.6B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Geneva Advisors withdrew a net $193M in Q3 2015, closing 98 positions and reducing 270 holdings. Its most notable exit was Potash Corp Of Saskatchewan, an estimated $21.6M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 19% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, Geneva Advisors opened a new position in Alphabet (Google) Class A worth $15.8M.
- Geneva Advisors's largest Q3 2015 buy was Alphabet (Google) Class A: 496,420 shares worth $15.8M.
- Geneva Advisors added most to Manhattan Associates in Q3 2015, an estimated $33.6M increase.
- Geneva Advisors's biggest Q3 2015 reduction was Biogen, cutting an estimated $49.9M.
- Geneva Advisors fully exited Potash Corp Of Saskatchewan in Q3 2015, selling an estimated $21.6M.
- Geneva Advisors's ten largest holdings make up 23% of its $4.96B portfolio in Q3 2015.
- Geneva Advisors opened 46 new positions and closed 98 in Q3 2015.
- Geneva Advisors's portfolio value fell 11% quarter-over-quarter to $4.96B.
Based on Geneva Advisors's 13F filing for Q3 2015, filed 3 Nov 2015.